I think they stated in the early days they werent interested in peer reviewed publications. They said the reason was they didnt want to give away how they do it. Cant recall where i heard or saw that though. I do share the same concerns that it all might be "too good to be true". I felt more relaxed when i saw the update and comments regarding the burns trial progress. It seemed to me this was at least "independant" and for them to state trial time had to be shortened due to results to date was impressive at the time. Since then though the lack of any further detail is a worty considering those updates were december. If the results had continued at same success rate it seems hard to believe this wouldnt be announced. Likewise James seemed to state the iv dose phase 1 was complete in that most recent interview, yet there has neen no anmouncement to indicate phase 1 iv completed successfully.
RCE Price at posting:
70.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)